期刊文献+

全身γ刀治疗不能手术Ⅰ和Ⅱ期非小细胞肺癌的临床结果 被引量:57

Clinical outcome of whole body gamma knife therapy inoperable stage Ⅰ/Ⅱ non-small cell lung
原文传递
导出
摘要 目的评价全身γ刀治疗Ⅰ、Ⅱ期非小细胞肺癌的疗效和放射反应。方法对43例因医学原因不能手术的Ⅰ、Ⅱ期非小细胞肺癌采用国产全身γ刀治疗,用真空负压袋固定体位、慢速CT定位扫描和三维治疗计划。PTV边缘总剂量50%剂量线50 Gy分10次2周完成(肺门肿大淋巴结40 Gy),中心最大剂量80~100 Gy,70 Gy覆盖GTV 90%以上。中位随访时间27个月。结果治疗后3~6个月,原发灶完全缓解率为63%,总有效率为95%。1、2、3年肿瘤局部控制率均为95%,1、2、3年总生存率Ⅰ期分别为100%、91%、91%、Ⅱ期分别为73%、64%、64%、Ⅰ+Ⅱ期分别为88%、78%、78%。肺早晚期反应较轻,3级放射性肺炎仅1例。放射性食管反应在周围型肺癌中没有,中心型肺癌的9例中,1级8例,2级1例。结论我国独创的全身γ刀治疗早期非小细胞肺癌局部控制率和生存率较好,而且放射反应轻,是一种安全有效的局部治疗手段。 Objective To evaluate the efficacy and toxicity of hypofractionated stereotactic body radiotherapy (SBRT) in patients with inoperable stage Ⅰ/Ⅱ non-small cell lung cancer. Methods Forty-three such patients were treated with home-manufactored stereotactic gamma-ray whole-body therapeutic system(whole body gamma-knife radiotherapy, QGD; OUR International Technology & Science Co., LTD, Shenabon, China) with 30 rotary conical-surface ^60Co sources on the target volume. For whole body-γ-knife treatment,a stereotactic body frame for exact tumor localization, reproducible vacuum fixation, low-speed computed tomagraphy simulation were conducted, which was followed by three-dimensional conformal radiotherapy planning. A total dose of 50 Gy was delivered at 5 Gy/fraction to the 50% isodose line covering the planned target volume, with a total dose of 70 Gy delivered at 7 Gy/fraction to the gross target volume. The median follow-up duration was 27 months. Results Three to six months after treatment, the complete response rate for whole body-gamma knife radiotherapy was 63%, and the overall response rate was 95%. The 1-, 2-, and 3-year local control rates were all 95%. In stage Ⅰ patients, the 1-, 2-, and 3-year overall survival rate was 100%, 91%, and 91%, respectively. In patients with stage Ⅱ, it was 73%, 64%, and 64%, respectively. In patients with stage Ⅰ+Ⅱ,it was 88% ,78% ,and 78%. Only 2 % (1/43) of the patients had grade 3 pneumonitis. Conclusion Our highly focused stereotactic body radiotherapy method has resulted in promising local control and survival with minimal toxicity.
出处 《中华放射肿瘤学杂志》 CSCD 北大核心 2007年第2期91-97,共7页 Chinese Journal of Radiation Oncology
关键词 非小细胞肺/立体定向放射疗法 全身Γ刀 治疗效果 临床结果 Carcinoma,n on-small lung/stereotactic radiotherapy Whole body-gamma knife Treatment result
  • 相关文献

参考文献17

  • 1Naruke T, Goya T, Tsuchiya B, et al. Prognosis and survival in resected lung carcinoma based on the new international staging system.J Thorac Cardiovasc Surg, 1988,96: 440-447.
  • 2Hayakawa K, Mitsuhashi N, Saito Y, et al. Limited field irradiation for medically inoperable patients with peripheral stage Ⅰ non-small cell lung cancer. Lung Cancer, 1999,26 : 137-142.
  • 3Sibley GS, Jamieson TA, Marks LB, et al. Radiotherapy alone for medically inoperable stage Ⅰ non-small cell lung cancer: the Duke experience. Int J Radiat Oncol Biol Phys, 1998,40:149-154.
  • 4张红星 殷蔚伯 张力军 等.放疗早期非小细胞肺癌[J].中国放射肿瘤学,1988,2:21-23.
  • 5Cheung PCF, Mackillop WJ, Dixon P, et al. Involved-field radiotherapy alone for early-stage non-small cell lung cancer. Int J Rediat Oncol Biol Phys,2000,48:703-710.
  • 6夏廷毅.头、体γ-刀的临床应用.见:申文江,王绿化,夏廷毅,主编.放射治疗学新技术进展.北京:北京科学技术出版社,2003.70-73.
  • 7夏廷毅,孙庆选,李平,于勇,崔纪青,范乃斌.体部γ-刀高分次剂量治疗Ⅰ~Ⅱ期非小细胞肺癌的临床研究[J].临床肿瘤学杂志,2005,10(1):20-24. 被引量:33
  • 8Onishi H, Kuriyama K, Komiyama T, et al. Clinical outcomes of stereotactic radiotherapy for stage Ⅰ non-small cell lung cancer using a novel irradiation technique: patient self-controlled breath-hold and beam switching using a combination of linear accelerator and CT scanner. Lung Cancer,2004 ,45 :45-55.
  • 9Nagata Y, Takayama K, Matsuo Y, et al. Clinical outcomes of a phase Ⅰ / Ⅱ study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame. Int J Radiat Oncol Biol Phys,2005,63:1427-1431.
  • 10McGarry RC, Papiez L, Williams M, et al. Stereotactic body radiation therapy of early-stage non-small-cell lung carcinoma: phase Ⅰ study. Int J Radiat Oncol Biol Phys,2005 ,63 :1010-1015.

二级参考文献16

  • 1Dosoretz DE. Katin M J, Blitzer PH,et al. Radiation the rapy in themanagement of medically inoperahle carcinoma of lung: results and implications for future treatment strategies[J]. Int J Radiat Oncol Biol Phys, 1992,24:3 - 9.
  • 2Martini N, Ruseh VW, Bains MS, et al. Factors influencing tenyear survixal in reseeted stages Ⅰ to Ⅲ a nonsmall cell lung cancer[J]. Thorac Cardiovase Surg, 1999,117 : 32 - 36.
  • 3Williams DE, Pairlero PC, Davis CS, et al. Survival of patients surgically treated for stage 1 lung cancer[J]. Thorac Cardiovasc Surg, 1981,82:70 - 76.
  • 4Krol ADG, Aussems P. Noordijik EM, et al. Local irradiation alone for peripheral stage I lung cancer:could we omit the elective regional nodal irradiation? [ J ] Int J Radiat Oncol Biol Phys.1996,34:297 - 302.
  • 5Hayakawa K, Mitsuhashi N, Saito Y,et al. Limited field irradiation for medically inoperable patients with peripheral stage Ⅰ nonsmall cell lung cancer[ J]. Lung Cancer, 1999,26:137 - 142.
  • 6Sibley GS, Jamieson TA, Marks LB, et al. Radiotherapy alone for medically inoperable stage Ⅰ non-small cell lung cancer:the duke experience[J].Int J Radiat Oncol Biol Phys. 1998,40: 149-154.
  • 7Cheung PCF, Mackillop WJ, Dixon P, et al. Involved-field radiotherapy alone for early-stage non-small cell lung cancer[ J]. Int J Radiat Oncol Biol Phys,2000 ,48 :703 - 710.
  • 8Kaskowitz L, Graham MV, Emami B, et al. Radiation therapy alone for stage Ⅰ non-small cell lung cancer[ J ]. Int J Radiat Oncol Biol Phys, 1993,27:517 - 523.
  • 9Noordijk EM, Poest-Clement EVD, Hemans J, et al. Radiotherapy as an alternative to surger? in elderly patients with respectable lung cancer [J].Radiother Oncol, 1988,13:83 - 89.
  • 10Cheung PCF, Yeung LTF. Basrur V. et al. Accelerated hypofraclionation for earlystage. Non small cell lung cancer[J]. Int J Radial Oneol Biol Phys,2002,54 : 1014 - 1023.

共引文献33

同被引文献498

引证文献57

二级引证文献252

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部